europe tissue processing systems Market

The Europe tissue processing systems market is expected to reach US$ 123.49 million by 2027 from US$ 87.74 million in 2019; it is estimated to grow at a CAGR of 4.5% from 2020 to 2027.

The growth of the market in Europe is primarily attributed to the rising prevalence of cancer and increasing number of diagnostic laboratories across Europe region. However, high cost of cancer diagnostics is expected to restrict the market growth during the forecast period.

Tissue processing involves preparing tissues for microscopic analysis by putting them in a tangible medium. It helps provide skinny and high-quality slices that can be mounted on the glass slides and properly stained to indicate normal and abnormal structures. Tissue processing systems are widely used in cancer diagnostic laboratories, where biopsy samples are processed for cancer diagnosis. The growing aging population, prone to chronic diseases such as cancer, drives the demand for regular diagnostic tests. As per estimates by Cancer Research UK, there were ~367,000 new cancer cases in the UK in 2017, i.e., ~1,000 cases were reported every day. Thus, increasing prevalence of cancer is likely to boost the demand for tissue processors to perform cancer diagnosis in the coming years. Moreover, the growing network of diagnostic laboratories across Europe is favoring the market growth.

The impact of COVID-19 pandemic on the tissue processing systems market in Europe has been minor in the last year. Restrictions on cross-border trade in several countries worldwide were the key factors that disrupted the supply and demand of tissue processing products. However, in the long run, the Europe market is expected to grow at a steady rate, owing to the precautions taken during the tissue processing system.

The Europe tissue processing systems market, by product, is segmented into tissue transfer processors and fluid transfer processors. The fluid transfer processors segment held the largest share of the market in 2019, and the tissue transfer processors segment is expected to register the highest CAGR in the market during the forecast period.

On the basis of volume, the Europe tissue processing systems market is segmented into small volume processors, medium volume processors, and large volume processors. The small volume processors segment held the largest share of the market in 2019, and the medium volume processors segment is anticipated to register the highest CAGR in the market during the forecast period.

The Europe tissue processing systems market, based on end user, is segmented into hospitals, pharmaceutical companies, research laboratories, and others. The hospitals segment held the largest share of the market in 2019; however, the pharmaceutical companies segment is estimated to register the highest CAGR in the market during the forecast period.

A few of the primary and secondary sources associated with this report on the Europe tissue processing systems market are the World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), and Joint Research Centre (JRC).